Transition Agreement and ReleaseTransition Agreement and Release • June 25th, 2020 • Selecta Biosciences Inc • Pharmaceutical preparations
This Transition Agreement and Release (“Agreement”) is made by and between ELONA KOGAN, J.D. (“Executive”) and SELECTA BIOSCIENCES, INC. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”) as of June 25, 2020 (the “Effective Date”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).
